highreslogo

  • News
  • Defence
  • Brian Phillips announces transition to ISO 9001:2015 accreditation

Defence News

On-Site Rapid Diagnostic Screening System for Bio-Security

Chelsea Technologies Group has developed of an ‘on-site rapid diagnostics screening system’ designed to detect and identify micro-organisms following a terrorist attack.

Over recent years CTG has developed a novel, low-cost, optical system for reading low-density protein microarrays, work that was done in partnership with Microtest Matrices Ltd. (MtM), a spin out from Imperial College, London. With additional government sponsorship under the Home Office’s CBRN programme, this advance has enabled Chelsea Technologies, MtM and The Health Inspection Agency to develop a fully automated portable microarray processing platform for on-site diagnosis, a step which had hitherto been inhibited by the sophistication and expense of the optical imaging techniques available for reading high density DNA arrays, which until now has been the main driver for the development of this format

The portable platform is designed to be rapidly deployed to any location in the event of a suspected terrorist attack allowing investigators to take samples from the immediate area of the incident – the walls, floor, people etc and screen them quickly to determine whether potentially harmful substances had been used in the attack. 

Dr John Attridge, Technical Director, Chelsea Technologies Group, said: “The platform is designed to be rapidly deployed in the event of unexplained clusters of acute illness or fatality, to screen for the presence of a comprehensive panel of micro-organisms that might be associated with a deliberate terrorist attack, allowing these to be ruled out as a potential threat early in any investigation. The microarray format that the team has developed can readily be adapted for other applications, including the detection of potentially harmful chemicals in water supplies or for multianalyte detection in the medical diagnostics market.”

Chelsea is keen to meet with organizations who may be interested in collaborating on commercialization of the platform.  For more information, please contact Ellen Keegan, Communications Manager, Tel +44 (0)20 8481 9019.

On-site rapid diagnostics screening system

The portable platform is designed to be rapidly deployed to any location in the event of a suspected terrorist attack allowing investigators to take samples from the immediate area of the incident – the walls, floor, people etc and screen them quickly to determine whether potentially harmful substances had been used in the attack.

Contact Us:

55 Central Avenue
West Molesey
Surrey
KT8 2QZ, UK

Tel: +44 (0)20 8481 9000
Fax: +44 (0)20 8941 9319

Join our mailing list